Screener
Discontinued — last reported Q2 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.
The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026. Open the filing →
- Filed
- Jul 28, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-087545
FAQ
- What is Kiniksa Pharmaceuticals International, plc's net debt?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported net debt of -$166.78M in Q2 2026.
- How has Kiniksa Pharmaceuticals International, plc's net debt changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's net debt increased by 8.5% year-over-year, from -$182.27M to -$166.78M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's net debt?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's net debt has grown at a 7.8% compound annual growth rate (CAGR), from -$107.05M to -$156.1M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Kiniksa Pharmaceuticals International, plc's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude